Finance

Beta
Lists
PODD:NASDAQ
Insulet Corp
$151.51
-1.12%
(-1.71) 1D
$151.51
0.00% (0.00)
After hours
Closed: Jun 8, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PODD...
Open
$151.98
High
$153.57
Low
$150.00
Mkt. cap
10.49B
Avg. vol.
1.75M
Volume
303.00
P/E ratio
35.26
52-wk high
$354.88
52-wk low
$140.63
EPS
$4.30
Beta
1.13
Shares outstanding
69.26M
No. of employees
5K
Open
$151.98
High
$153.57
Low
$150.00
Mkt. cap
10.49B
Avg. vol.
1.75M
Volume
303.00
P/E ratio
35.26
52-wk high
$354.88
52-wk low
$140.63
EPS
$4.30
Beta
1.13
Shares outstanding
69.26M
No. of employees
5K
Analyst outlook
Analyst Ratings
Based on 21 analysts giving stock ratings to PODD in the past 3 months
Strong Buy
Buy
17
Hold
3
Sell
1
12 month forecast
Based on 21 Wall Street analysts offering 12 month price targets for PODD in the last 3 months.
Highest
Current $151.51
$294.00 (+94.05%)
Average
$231.11 (+52.54%)
Lowest
$165.00 (+8.90%)
News stories
From sources across the web
About Insulet Corp
CEOAshley Mcevoy
Employees5.4K
Founded2000
HeadquartersActon, Massachusetts, United States
SectorMedical device
Last report
May 6, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$1.42 / $1.19
+19.26%beat
Revenue / Est. (USD)
761.70M / 730.10M
+4.33%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
649.10M
706.30M
783.80M
761.70M
Cost of goods sold
196.90M
196.20M
215.20M
232.70M
Cost of revenue
196.90M
196.20M
215.20M
232.70M
Research and development expenses
73.40M
77.20M
90.90M
89.70M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
257.70M
315.20M
331.40M
317.20M
Operating expense
331.10M
392.40M
422.30M
406.90M
Total operating expenses
528.00M
588.60M
637.50M
639.60M
Operating income
121.10M
117.70M
146.30M
122.10M
Other non operating income
1.20M
12.10M
1.20M
700.00K
EBT including unusual items
28.40M
122.80M
140.10M
113.00M
EBT excluding unusual items
112.80M
122.80M
140.10M
113.00M
Income tax expense
5.90M
35.20M
38.50M
21.90M
Effective tax rate
20.77%
28.66%
27.48%
19.38%
Other operating expenses
-
-
-
-
Net income
22.50M
87.60M
101.60M
91.10M
Net profit margin
3.47%
12.40%
12.96%
11.96%
Earnings per share
1.17
1.24
1.55
1.42
Interest and investment income
10.10M
8.60M
5.70M
4.90M
Interest expense
-19.60M
-15.60M
-14.90M
-14.70M
Net interest expenses
-9.50M
-7.00M
-9.20M
-9.80M
Depreciation and amortization charges
-
-
-
-
EBITDA
143.40M
139.70M
170.70M
148.30M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more